Trending

Endo

FDA makes unprecedented move, asks Endo to pull painkiller from market

FDA makes unprecedented move, asks Endo to pull painkiller from market

Regulator concerned about potential abuse of Opana ER

X

FDA makes unprecedented move, asks Endo to pull painkiller from market

https://pharmaphorum.com/news/fda-asks-endo-pull-painkiller-market/

Risks of Endo painkiller outweigh benefits, say FDA advisers

Risks of Endo painkiller outweigh benefits, say FDA advisers

The US regulator must make a decision on Endo Pharmaceuticals’ opioid painkiller, after its independent advisers said that

X

Risks of Endo painkiller outweigh benefits, say FDA advisers

https://pharmaphorum.com/news/risks-endo-painkiller-outweigh-benefits-say-fda-advisers/

FDA delays decision on abuse deterrence data on Endo painkiller

FDA delays decision on abuse deterrence data on Endo painkiller

Data could be used to fend off generic competition.

X

FDA delays decision on abuse deterrence data on Endo painkiller

https://pharmaphorum.com/news/fda-delays-decision-on-key-abuse-deterrence-data-on-endo-painkiller/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com